The anti-apoptotic MAP kinase pathway is inhibited in NIH3T3 fibroblasts with increased expression of phosphatidylinositol transfer protein β

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1773, Issue 11, 2007, Pages 1664-1671

  Schenning, Martijn ^a   van Tiel, Claudia M ^a   Wirtz, Karel W A ^a   Snoek, Gerry T ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Eicosanoids; Phosphatidylinositol metabolism; Phospholipid transfer protein; Sphingomyelin metabolism

Indexed keywords

CARRIER PROTEIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL TRANSFER PROTEIN BETA; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROTEIN KINASE C; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROTECTION; CELL STRAIN 3T3; CELL SURVIVAL; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FIBROBLAST; FIBROBLAST CULTURE; MOUSE; NONHUMAN; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; ULTRAVIOLET IRRADIATION;

ANIMALS; APOPTOSIS; CELL SURVIVAL; CULTURE MEDIA, CONDITIONED; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DINOPROSTONE; ENZYME ACTIVATION; ENZYME INHIBITORS; FIBROBLASTS; GENE EXPRESSION; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, BIOLOGICAL; MUTANT PROTEINS; NIH 3T3 CELLS; PHOSPHOLIPID TRANSFER PROTEINS; ULTRAVIOLET RAYS;

EID: 35549007074     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2007.06.004     Document Type: Article

References (46)

1. Tanaka S., Yamashita S., and Hosaka K. Cloning and expression of human cDNA encoding phosphatidylinositol transfer protein beta. Biochim. Biophys. Acta 1259 (1995) 199-202
2. Wirtz K.W. Phospholipid transfer proteins revisited. Biochem. J. 324 Pt 2 (1997) 353-360
3. De Vries K.J., Westerman J., Bastiaens P.I., Jovin T.M., Wirtz K.W., and Snoek G.T. Fluorescently labeled phosphatidylinositol transfer protein isoforms (alpha and beta), microinjected into fetal bovine heart endothelial cells, are targeted to distinct intracellular sites. Exp. Cell Res. 227 (1996) 33-39
4. Bankaitis V.A. Cell biology. Slick recruitment to the Golgi. Science 295 (2002) 290-291
5. Alb Jr. J.G., Cortese J.D., Phillips S.E., Albin R.L., Nagy T.R., and Hamilton B.A. Mice lacking phosphatidylinositol transfer protein-alpha exhibit spinocerebellar degeneration, intestinal and hepatic steatosis, and hypoglycemia. J. Biol. Chem. 278 (2003) 33501-33518
6. Alb Jr. J.G., Phillips S.E., Rostand K., Cui X., Pinxteren J., Cotlin L., Manning T., Guo S., York J.D., Sontheimer H., Collawn J.F., and Bankaitis V.A. Genetic ablation of phosphatidylinositol transfer protein function in murine embryonic stem cells. Mol. Biol. Cell 13 (2002) 739-754
7. Van Tiel C.M., Luberto C., Snoek G.T., Hannun Y.A., and Wirtz K.W. Rapid replenishment of sphingomyelin in the plasma membrane upon degradation by sphingomyelinase in NIH3T3 cells overexpressing the phosphatidylinositol transfer protein beta. Biochem. J. 346 Pt 2 (2000) 537-543
8. de Vries K.J., Heinrichs A.A., Cunningham E., Brunink F., Westerman J., Somerharju P.J., Cockcroft S., Wirtz K.W., and Snoek G.T. An isoform of the phosphatidylinositol-transfer protein transfers sphingomyelin and is associated with the Golgi system. Biochem. J. 310 Pt 2 (1995) 643-649
9. van Tiel C.M., Westerman J., Paasman M.A., Hoebens M.M., Wirtz K.W., and Snoek G.T. The Golgi localization of phosphatidylinositol transfer protein beta requires the protein kinase C-dependent phosphorylation of serine 262 and is essential for maintaining plasma membrane sphingomyelin levels. J. Biol. Chem. 277 (2002) 22447-22452
10. Snoek G.T., Van Tiel C.M., and Egmond M.R. Structure-function relationships of phosphatidylinositol transfer proteins: involvement of phosphorylation sites. Biochimie 86 (2004) 857-864
11. Bankaitis V.A., Aitken J.R., Cleves A.E., and Dowhan W. An essential role for a phospholipid transfer protein in yeast Golgi function. Nature 347 (1990) 561-562
12. Snoek G.T., Berrie C.P., Geijtenbeek T.B., van der Helm H.A., Cadee J.A., Iurisci C., Corda D., and Wirtz K.W. Overexpression of phosphatidylinositol transfer protein alpha in NIH3T3 cells activates a phospholipase A. J. Biol. Chem. 274 (1999) 35393-35399
13. Schenning M., van Tiel C.M., Van Manen D., Stam J.C., Gadella B.M., Wirtz K.W., and Snoek G.T. Phosphatidylinositol transfer protein alpha regulates growth and apoptosis of NIH3T3 cells: involvement of a cannabinoid 1-like receptor. J. Lipid Res. 45 (2004) 1555-1564
14. Bunte H., Schenning M., Sodaar P., Bar D.P., Wirtz K.W., van Muiswinkel F.L., and Snoek G.T. A phosphatidylinositol transfer protein alpha-dependent survival factor protects cultured primary neurons against serum deprivation-induced cell death. J. Neurochem. 97 (2006) 707-715
15. van Tiel C.M., Schenning M., Snoek G.T., and Wirtz K.W. Overexpression of phosphatidylinositol transfer protein beta in NIH3T3 cells has a stimulatory effect on sphingomyelin synthesis and apoptosis. Biochim. Biophys. Acta 1636 (2004) 151-158
16. Tai H.H., Tai C.L., and Hollander C.S. Biosynthesis of prostaglandins in rabbit kidney medulla. Properties of prostaglandin synthase. Biochem. J. 154 (1976) 257-264
17. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
18. Bligh E.G., and Dyer W.J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37 (1959) 911-917
19. Luberto C., and Hannun Y.A. Sphingomyelin synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation. Does sphingomyelin synthase account for the putative phosphatidylcholine-specific phospholipase C?. J. Biol. Chem. 273 (1998) 14550-14559
20. Colombaioni L., and Garcia-Gil M. Sphingolipid metabolites in neural signalling and function. Brain Res. Brain Res. Rev. 46 (2004) 328-355
21. Ogretmen B., and Hannun Y.A. Biologically active sphingolipids in cancer pathogenesis and treatment. Nat. Rev., Cancer 4 (2004) 604-616
22. Hannun Y.A., and Obeid L.M. Mechanisms of ceramide-mediated apoptosis. Adv. Exp. Med. Biol. 407 (1997) 145-149
23. van Blitterswijk W.J., van der Luit A.H., Veldman R.J., Verheij M., and Borst J. Ceramide: second messenger or modulator of membrane structure and dynamics?. Biochem. J. 369 (2003) 199-211
24. Ramstedt B., and Slotte J.P. Separation and purification of sphingomyelin diastereomers by high-performance liquid chromatography. Anal. Biochem. 282 (2000) 245-249
25. Ramstedt B., and Slotte J.P. Membrane properties of sphingomyelins. FEBS Lett. 531 (2002) 33-37
26. Sugiura H., Liu X., Togo S., Kobayashi T., Shen L., Kawasaki S., Kamio K., Wang X.Q., Mao L.J., and Rennard S.I. Prostaglandin E(2) protects human lung fibroblasts from cigarette smoke extract-induced apoptosis via EP(2) receptor activation. J. Cell. Physiol. 210 (2007) 99-110
27. Leahy K.M., Ornberg R.L., Wang Y., Zweifel B.S., Koki A.T., and Masferrer J.L. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. Cancer Res. 62 (2002) 625-631
28. Iniguez M.A., Rodriguez A., Volpert O.V., Fresno M., and Redondo J.M. Cyclooxygenase-2: a therapeutic target in angiogenesis. Trends Mol. Med. 9 (2003) 73-78
29. Parolaro D., Massi P., Rubino T., and Monti E. Endocannabinoids in the immune system and cancer. Prostaglandins Leukot. Essent. Fat. Acids 66 (2002) 319-332
30. Lavoie J.N., Rivard N., L'Allemain G., and Pouyssegur J. A temporal and biochemical link between growth factor-activated MAP kinases, cyclin D1 induction and cell cycle entry. Prog. Cell Cycle Res. 2 (1996) 49-58
31. Le Gall M., Chambard J.C., Breittmayer J.P., Grall D., Pouyssegur J., and Van Obberghen-Schilling E. The p42/p44 MAP kinase pathway prevents apoptosis induced by anchorage and serum removal. Mol. Biol. Cell 11 (2000) 1103-1112
32. Berra E., Milanini J., Richard D.E., Le Gall M., Vinals F., Gothie E., Roux D., Pages G., and Pouyssegur J. Signaling angiogenesis via p42/p44 MAP kinase and hypoxia. Biochem. Pharmacol. 60 (2000) 1171-1178
33. Pages G., Milanini J., Richard D.E., Berra E., Gothie E., Vinals F., and Pouyssegur J. Signaling angiogenesis via p42/p44 MAP kinase cascade. Ann. N. Y. Acad. Sci. 902 (2000) 187-200
34. Phillips S.E., Ile K.E., Boukhelifa M., Huijbregts R.P., and Bankaitis V.A. Specific and nonspecific membrane-binding determinants cooperate in targeting phosphatidylinositol transfer protein beta-isoform to the mammalian trans-Golgi network. Mol. Biol. Cell 17 (2006) 2498-2512
35. Morgan C.P., Allen-Baume V., Radulovic M., Li M., Skippen A., and Cockcroft S. Differential expression of a C-terminal splice variant of phosphatidylinositol transfer protein beta lacking the constitutive-phosphorylated Ser262 that localizes to the Golgi compartment. Biochem. J. 398 (2006) 411-421
36. Hetman M., Kanning K., Cavanaugh J.E., and Xia Z. Neuroprotection by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase. J. Biol. Chem. 274 (1999) 22569-22580
37. Crofford L.J. COX-1 and COX-2 tissue expression: implications and predictions. J. Rheumatol., Suppl. 49 (1997) 15-19
38. Hara A., Yoshimi N., Niwa M., Ino N., and Mori H. Apoptosis induced by NS-398, a selective cyclooxygenase-2 inhibitor, in human colorectal cancer cell lines. Jpn. J. Cancer Res. 88 (1997) 600-604
39. Cao Y., and Prescott S.M. Many actions of cyclooxygenase-2 in cellular dynamics and in cancer. J. Cell. Physiol. 190 (2002) 279-286
40. Ding X.Z., Tong W.G., and Adrian T.E. Blockade of cyclooxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Anticancer Res. 20 (2000) 2625-2631
41. Hida T., Kozaki K., Muramatsu H., Masuda A., Shimizu S., Mitsudomi T., Sugiura T., Ogawa M., and Takahashi T. Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines. Clin. Cancer Res. 6 (2000) 2006-20011
42. Hsu A.L., Ching T.T., Wang D.S., Song X., Rangnekar V.M., and Chen C.S. The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2. J. Biol. Chem. 275 (2000) 11397-11403
43. Kroesen B.J., Jacobs S., Pettus B.J., Sietsma H., Kok J.W., Hannun Y.A., and de Leij L.F. BcR-induced apoptosis involves differential regulation of C16 and C24-ceramide formation and sphingolipid-dependent activation of the proteasome. J. Biol. Chem. 278 (2003) 14723-14731
44. Obeid L.M., Linardic C.M., Karolak L.A., and Hannun Y.A. Programmed cell death induced by ceramide. Science 259 (1993) 1769-1771
45. Santana P., Pena L.A., Haimovitz-Friedman A., Martin S., Green D., McLoughlin M., Cordon-Cardo C., Schuchman E.H., Fuks Z., and Kolesnick R. Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell 86 (1996) 189-199
46. Niemela P.S., Hyvonen M.T., and Vattulainen I. Influence of chain length and unsaturation on sphingomyelin bilayers. Biophys. J. 90 (2006) 851-863